Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

ClinicalTrials.gov ID: NCT04614337

Public ClinicalTrials.gov record NCT04614337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Idiopathic Growth Hormone Deficiency (GHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-national trial. The goals of the trial are to study LUM-201 as a possible treatment for Pediatric Growth Hormone Deficiency (PGHD) and investigate a predictive enrichment marker (PEM) strategy to select subjects likely to respond to therapy with LUM-201.

Study identification

NCT ID
NCT04614337
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Lumos Pharma
Industry
Enrollment
104 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2020 (Actual)
Primary completion
Sep 4, 2024 (Actual)
Completion
Sep 4, 2024 (Actual)
Last update posted
Jun 17, 2026

2020 – 2024

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Center of Excellence in Diabetes and Endocrinology Sacramento California 95821 —
Rady Children's Hospital San Diego California 92123 —
Pediatric Endocrine Associates Greenwood Village Colorado 80111 —
Children's National Hospital Washington D.C. District of Columbia 20010 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
University of Iowa Iowa City Iowa 52242 —
Novak Center For Childrens Health Louisville Kentucky 40202 —
UMass Memorial Medical Center Worcester Massachusetts 01655 —
M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic Minneapolis Minnesota 55454 —
Children's Minnesota Saint Paul Minnesota 55102 —
The Children's Mercy Hospital Kansas City Missouri 64111 —
UBMD Pediatrics Buffalo New York 14203 —
The Mount Sinai Hospital Mount Sinai New York 30093 —
NYU Grossman School of Medicine New York New York 10016 —
Nationwide Children's Hospital Columbus Ohio 43205 —
University of Oklahoma Health Sciences Center, Pediatric Diabetes and Endocrinology Oklahoma City Oklahoma 73104 —
Penn State College of Medicine Hershey Pennsylvania 17033 —
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Medical University of South Carolina Charleston South Carolina 29425 —
Texas Tech University Health Sciences Center Amarillo Texas 79106 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229 —
University of Virginia Health System Charlottesville Virginia 22908 —
Seattle Children's Hospital Seattle Washington 98105 —
MultiCare Institute for Research and Innovation Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04614337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04614337 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →